(NIH/National Institute of Allergy and Infectious Diseases) An international team has begun patient enrollment in a clinical trial testing investigational Ebola therapies in the Democratic Republic of the Congo. The randomized, controlled trial is enrolling patients of any age with confirmed Ebola virus disease (DRC). The trial is led and funded by the National Institute for Biomedical Research, part of the DRC Ministry of Health, and the National Institute of Allergy and Infectious Diseases (NIAID). (Source: EurekAlert! - Infectious and Emerging Diseases)
MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2Av2vTr
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.